Bio-Rad Laboratories BIO
NYSE BIO
$368.86 -8.11 (-2.15%)
As of: Sep 10, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Change in Receivables (2009 - 2017)

Bio-Rad Laboratories' (BIO) quarterly Change in Receivables came in at $20.6 million in Q3 2017, up 3629.67% year-over-year from $551737.2 in Q3 2016, and up 136.66% quarter-over-quarter from $8.7 million in Q2 2017.

Analysis

Bio-Rad Laboratories (BIO) Change in Receivables (2009 - 2017) Analysis & Trends

Bio-Rad Laboratories (BIO) has reported Change in Receivables for 9 consecutive years, with $20.6 million the latest figure, recorded in Q3 2017.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Thermo Fisher Scientific 223.99 Bn 219.93 Bn 8.34 Bn -
2 Danaher 141.56 Bn 137.22 Bn 3.61 Bn -71.00 Mn
3 Agilent Technologies 40.36 Bn 38.60 Bn 1.04 Bn -22.00 Mn
4 Illumina 30.41 Bn 29.24 Bn 770.00 Mn 26.00 Mn
5 Revvity 13.50 Bn 12.48 Bn 416.87 Mn 17.63 Mn
6 Bio-Techne 11.25 Bn 10.98 Bn 211.39 Mn 2.87 Mn
7 Bio-Rad Laboratories 9.88 Bn 8.26 Bn 345.80 Mn -
8 Repligen 9.29 Bn 8.28 Bn 110.04 Mn 7.55 Mn
9 10x Genomics 8.62 Bn 8.06 Bn 112.50 Mn 8.51 Mn
10 Bruker 8.16 Bn 7.94 Bn 416.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 20.58 Mn
Jun 30, 2017 8.70 Mn
Mar 31, 2017 -6.85 Mn
Sep 30, 2016 -583,000.00
Jun 30, 2016 -12.08 Mn
Mar 31, 2016 -19.99 Mn
Sep 30, 2015 -7.14 Mn
Jun 30, 2015 5.71 Mn
Mar 31, 2015 -15.57 Mn
Sep 30, 2014 -5.08 Mn
Jun 30, 2014 -6.50 Mn
Mar 31, 2014 -39.57 Mn
Sep 30, 2013 -21.28 Mn
Jun 30, 2013 20.93 Mn
Mar 31, 2013 -14.45 Mn
Sep 30, 2012 -4.95 Mn
Jun 30, 2012 -2.35 Mn
Mar 31, 2012 -17.58 Mn
Sep 30, 2011 1.03 Mn
Jun 30, 2011 -1.76 Mn